Literature DB >> 20103470

Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases.

Joe W Krayer1, Renata S Leite, Keith L Kirkwood.   

Abstract

Periodontal diseases are initiated by subgingival periodontal pathogens in susceptible periodontal sites. The host immune response toward periodontal pathogens helps to sustain periodontal disease and eventual alveolar bone loss. Numerous adjunctive therapeutic strategies have evolved to manage periodontal diseases. Systemic and local antibiotics, antiseptics, and past and future host immune modulatory agents are reviewed and discussed to facilitate the dental practitioner's appreciation of this ever-growing field in clinical periodontics.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20103470      PMCID： PMC3086469          DOI： 10.1016/j.cden.2009.08.010

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN： 0011-8532


  81 in total

Review 1.  Evidence of bacterial etiology: a historical perspective.

Authors:  S S Socransky; A D Haffajee
Journal:  Periodontol 2000       Date:  1994-06       Impact factor: 7.589

2.  IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis.

Authors:  R Assuma; T Oates; D Cochran; S Amar; D T Graves
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

3.  Meta-analysis of the effect of systemic metronidazole as an adjunct to scaling and root planing for adult periodontitis.

Authors:  J R Elter; H P Lawrence; S Offenbacher; J D Beck
Journal:  J Periodontal Res       Date:  1997-08       Impact factor: 4.419

Review 4.  The acquisition of antibiotic resistance in the periodontal microflora.

Authors:  C B Walker
Journal:  Periodontol 2000       Date:  1996-02       Impact factor: 7.589

Review 5.  Periodontal diseases: pathogenesis.

Authors:  S Offenbacher
Journal:  Ann Periodontol       Date:  1996-11

Review 6.  Impact of advances in diabetes care on dental treatment of the diabetic patient.

Authors:  B L Mealey
Journal:  Compend Contin Educ Dent       Date:  1998-01

Review 7.  Bisphosphonates: preclinical aspects and use in osteoporosis.

Authors:  H A Fleisch
Journal:  Ann Med       Date:  1997-02       Impact factor: 4.709

8.  Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: effect of micocycline therapy.

Authors:  K M Chang; M E Ryan; L M Golub; N S Ramamurthy; T F McNamara
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1996-03

9.  Alendronate treatment of naturally-occurring periodontitis in beagle dogs.

Authors:  M S Reddy; T W Weatherford; C A Smith; B D West; M K Jeffcoat; T M Jacks
Journal:  J Periodontol       Date:  1995-03       Impact factor: 6.993

10.  Induction of COX-2 expression by mechanical tension force in human periodontal ligament cells.

Authors:  N Shimizu; Y Ozawa; M Yamaguchi; T Goseki; K Ohzeki; Y Abiko
Journal:  J Periodontol       Date:  1998-06       Impact factor: 6.993
View more
  21 in total

Review 1.  Paradigm shift in the pharmacological management of periodontal diseases.

Authors:  Hatice Hasturk; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Front Oral Biol       Date:  2011-11-11

2.  Antibacterial effects of blackberry extract target periodontopathogens.

Authors:  O A González; C Escamilla; R J Danaher; J Dai; J L Ebersole; R J Mumper; C S Miller
Journal:  J Periodontal Res       Date:  2012-07-19       Impact factor: 4.419

3.  Local Application of Pyrophosphorylated Simvastatin Prevents Experimental Periodontitis.

Authors:  Xiaobei Wang; Zhenshan Jia; Yosif Almoshari; Subodh M Lele; Richard A Reinhardt; Dong Wang
Journal:  Pharm Res       Date:  2018-06-25       Impact factor: 4.200

Review 4.  Microbiota and nonalcoholic steatohepatitis.

Authors:  Kento Imajo; Masato Yoneda; Yuji Ogawa; Koichiro Wada; Atsushi Nakajima
Journal:  Semin Immunopathol       Date:  2013-12-14       Impact factor: 9.623

5.  Functionalized nanoparticles containing MKP-1 agonists reduce periodontal bone loss.

Authors:  Michael S Valerio; Frank Alexis; Keith L Kirkwood
Journal:  J Periodontol       Date:  2019-03-13       Impact factor: 6.993

6.  Inhibition of the histone demethylase KDM4B leads to activation of KDM1A, attenuates bacterial-induced pro-inflammatory cytokine release, and reduces osteoclastogenesis.

Authors:  Joy E Kirkpatrick; Keith L Kirkwood; Patrick M Woster
Journal:  Epigenetics       Date:  2018-08-07       Impact factor: 4.528

7.  Influence of Titania Nanotubes Diameter on Its Antibacterial Efficacy against Periodontal Pathogens: An In vitro Analysis.

Authors:  S Raja Rajeswari; Vidyashree Nandini; Agilan Perumal; Triveni Gowda
Journal:  J Pharm Bioallied Sci       Date:  2021-06-05

Review 8.  Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.

Authors:  D C Mastellos; D Ricklin; E Hajishengallis; G Hajishengallis; J D Lambris
Journal:  Mol Oral Microbiol       Date:  2015-10-07       Impact factor: 3.563

Review 9.  Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.

Authors:  George Hajishengallis; Tomoki Maekawa; Toshiharu Abe; Evlambia Hajishengallis; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

10.  Treatment modalities and evaluation models for periodontitis.

Authors:  Mohammad Tariq; Zeenat Iqbal; Javed Ali; Sanjula Baboota; Sushama Talegaonkar; Zulfiqar Ahmad; Jasjeet K Sahni
Journal:  Int J Pharm Investig       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.